REN

AL C

ARE

BioScan touch i8®

CLINICAL ASSESSMENT FOR HEMODIALYSIS & PERITONEAL DIALYSIS PATIENTS

2

BioScan touch i8®SMART BODY COMPOSITION MONITOR THAT SPEAKS THE LANGUAGE OF THE BODY

• 2D/3D visualization

• Multi-frequency

• 4 or 8 independent multi-sensors

• User-configurable

3

DRY WEIGHT ASSESSMENT REMAINS A MAJOR CHALLENGE ESPECIALLY WHEN A NUMBER OF COMORBID COMPLICATIONS ARE PRESENT

BioScan touch i8 is fast, easy, and accurate: • Provides early assessment to help prevent cardiovascular morbidity in dialysis patients• Monitors euvolemia status to normalize blood pressure, preventing cardiovascular

complications• Detects and understands changes in body composition, particularly malnutrition, which is

common in patients receiving long-term hemodialysis

4

BENEFITS FOR THE PATIENT• Better determination of dry weight target1

• Assesses fluid overload and helps control blood pressure2

• reduce both hyper- and hypotensive episodes3

• Minimizes [KC1] cramps and post-dialysis fatigue4

• Lessens the risk of possible cardiovascular complications and death5

• might preserve renal function6

• Provides individual Min/Max targets of all parameters measured

• Detects malnutrition7

• Identifies the loss of muscle mass early on8

• Improves quality of life9

1. Machek P, et al. Nephrol Dial Transplant.2010;25:538-5442. Moissl U, et al. Clin J Am Soc Nephrol.2013 Sep; 8(9): 1575-823. Abreo AP, et al. Hemodial Int.2015 Oct;19(4): 536-424. Machek P, et al. Nephrol Dial Transplant.2010;25:538-5445. Kim YJ, et al. Kidney Res Clin Pract. 2015 Dec;34 (4):212-8

6. Oei EL, et al.Blood Purif 2015;39:32-367. V Jha, et al. Kidney Int. 2006 May; 69 (9): 1649 - 538. Alizadehkhaiyat O, et al. Eur J Appl Physiol. 2014 Jan; 114 (1): 117-859. Moissl U, et al. Clin J Am Soc Nephrol.2013 Sep; 8(9): 1575-82

5

POTENTIAL BENEFITS FOR THEHEALTHCARE PROVIDER• Reduction in hospital admissions1

• More stable and consistent HD sessions for patients2

• Better use of resources

The flexibility of BioScan touch i8 allows clinicians for the first time to conduct tests on patients at every stage of dialysis.

PRE, MID, AND POST ASSESSMENTS ON ALL DIALYSIS PATIENTS

Assessments with BioScan touch i8 are seamless, quick, and easy. They can be performed in supine and semi re-cumbent patients.

BioScan touch i8 offers full flexibility for the operator to configure measurements as desired.

1. Kim YJ, et al. Kidney Res Clin Pract. 2015 Dec;34 (4):212-82. Moissl U, et al. Clin J Am Soc Nephrol.2013 Sep; 8(9): 1575-82

6

EARLY SCREENING & IDENTIFICATION OF PATIENTS AT RISKWith BioScan touch i8, healthcare providers can establish baseline needs and track changes over time. This ultimately improves patient outcome and discharge timing, while simultaneously decreasing long term complications. Because early detection leads to better choices:

• Early screening of Total Body Water (TBW) • Monitors overhydration and dehydration• Pre, Mid, Post-assessment• Ultrafiltration Rate (UFR) and Kt/V estimations• Avoids subjective, empirical, and time consuming evaluations

The most challenging target of dialysis treatment is to achieve and maintain an euvolemic state. Currently, euvolemic and dry weight assessments are performed on a trial and error basis.

7

ASSESSMENT FOR ALL PATIENT TYPES: HD, PD, PEDIATRIC

TAKE CONTROLBEFORE, DURING, AND AFTER TREATMENT

• Dry Weight• Overhydration and dehydration status• Extracellular water• Intracellular water• Total body water• Ultrafiltration Rate (UFR)• Kt/V• Fat free mass hydration• Malnutrition index• Body cell mass• Cellular biomarker

• 10.1” flat screen

• Crystal clear HD display

• Multi-screen

• Pinch/zoom capable

• Wireless data communication

• No technical knowledge required

8

THE BODY COMPOSITION MONITOR OF TOMORROW, TODAYDEFINING NEW STANDARDS

BioScan touch i8 provides clinicians a graphical visualization of patient data, as well as targets and goals achieved. This tracking allows historical patient data to be analyzed and compared over time.

Important estimations of UFR and Kt/V are automatically provided in order to optimize dialysis doses. Test can be performed pre, mid or post treatment, while fluid changes are calculated automatically.

9

SMART TECHNOLOGY THAT IS SEAMLESS, QUICK, AND EASY

• Security enabled• Data storage for over 500,000

tests

• 10.1” touch screen• Crystal clear HD multi-screen

Pinch/zoom capable

• Stand alone device• No PC required• No tech knowledge required

• Graphical visualization of data• Individual Min/Max targets

• WIFI, Bluetooth, Ethernet, USB wireless data communications

• Data transfer to PC via CSV - and Excel files

• 1 Channel - 4 electrode test• 2 Channel - 8 electrode test • Auto-calibration maintains

optimum accuracy

• Light and portable• Fluid motion• Multi-language

• Over 12 hours of continuous use • Smart rechargeable battery

10

A DETAILED SCREENING TOOL

BIOSCAN touch i8® RESULTS DISPLAYED

Dry Weight• Excess Fluid• Over/Dehydration

Fluids• Extracellular Fluid• Intracellular Water Volume • Extracellular Water Volume • Extracellular Water Lt• Total Body Water Volume • Intracellular Water Lt • Intracellular Water % • Extracellular Water % • Total Body Water Lt • Total Body Water % • Extracellular / Intracellular Water• Extracellular Water / Total Body Water• Intracellular Water / Total Body Water• Interstitial-Fluid Extravascular (optional)• Plasma-Fluid (Intravascular) (optional)

Body Cell Mass• Muscle Mass %• Fat Free Mass• Extracellular Mass

Body Fat Composition• Fat %• Fat Mass• Body Volume• Body Mass Index• Resting Metabolic Rate

GFR Assessment• Glomerular Filtration Rate• Creatinine Clearance

Bone Composition• Bone Density• Bone Minerals

Minerals• Total Body Potassium • Total Body Calcium• Protein Mass• Mineral Mass• Glycogen Mass

Raw Data• Impedance• Phase Angle• Resistance • Reactance• Capacitance • Muscle Mass

MIN/MAX TARGETS FOR A L L PA R A ME T ER S

11

12

SMART CALIBRATION

• Height/Weight

• Ages 5 – 99

• Supine or semi recumbent

• Average body composition/ Obese/ Anorexic/ Malnourished

13

14

TAKE CONTROL, BE PROACTIVE, AND MAKE A DIFFERENCE

BECAUSE EVERY LIFE DESERVES AFFORDABLE CARE

BioScan touch i8®

15

TECHNICAL SPECIFICATIONSTechnique Multi-frequency Bioelectrical Impedance Analysis & FDSA+ using tetra-

polar method

Display Languages Multi-language configuration

Display 10.1” touch screen

Frequencies Multi-frequency 5.0 kHz, 50.0 kHz, 100 kHz, 200 kHz

Test Current 600 uA RMS approx

Impedance Range 1 to 1200 ohms (Full Scale Deflection (FSD) is 1200 R)

Impedance Resolution 1 - 100 R range: 0.1 R , 100 - 1100 R range: 1 R

Impedance Accuracy Impedance to within 1% of FSD, +5 R across 100 - 1100 R range and +5 R across 1-100 R range

Phase Range 1° - 35°

Phase Resolution 0.05°

Phase Accuracy 2% of FSD, +0.5° (where FSD is 35°), across 1° - 30°

Resistance Range 1 - 1200 R

Resistance Resolution 1 - 100 R range: 0.1 R , 100 - 1100 R range: 1 R

Reactance Range 0 - 580 R

Reactance Resolution 0.1R

MT950 BioScan touch i8 Estimation

DATA OUTPUT RESOLUTION TBW - ECW - ICW in increments of 0.1 litres FFM - FM in increments of 0.1kg BCM - 0.1kg

User Memory Internal storage approx. 100,000.

Ambient Temperature Storage: +5°C to 40°C Use: +15°C to 35°C

Relative Humidity 30% to 65% non-condensing

Main Power 115 to 250 v AC via charger

Power 10.8 VDC Li-ion battery pack (99 Wh)

Charger 15VDC external input power source (4 Amps max) Smart Battery Charging System built into power PCB

Weight 3.5 kg approx. (with base unit)

Dimensions Length: 350 mm, Height: 325 mm, Width: 155 mm (with base)

Service No serviceable parts

Guarantee 12 months parts and labor* (excluding disposable items, cables, and electrodes)

* Maltron reserves the right to make design changes without notice as part of our continuous program of product development. Maltron and the Maltron logo are Registered Trademarks of Maltron International Limited. Maltron shall not be liable for any editorial or technical errors omitted. Copyright 2017. Maltron International. All rights reserved.

NIPRO AUSTRIA GMBH : Divischgasse 4, 1210 Wien, AUSTRIA | T: +43 (0)2 910 712 | T: +43 (0)2 910 713NIPRO EUROPE NV - EGYPT : Nile City Towers, 22nd Floor, North Tower, Nile City, Towers, Cornich El Nile, 11624 Ramelt Beaulac, Cairo, EGYPTNIPRO EUROPE - FRANCE : Biopôle Clermont-Limagne, 63360 Saint Beauzire, FRANCE | T: +33 (0)473 33 41 00 | F: +33 (0)473 33 41 09NIPRO MEDICAL GERMANY GMBH : Kokkolastrasse 5, 40882 Ratingen, GERMANY | T: +49 (0) 2102 564 60 81 | F: +49 (0) 2102 564 60 90NIPRO EUROPE - ITALY : Centro Direzionale Milanofiori, Strada 1 - Palazzo F/1, 20090 Assago (Milano), ITALY | T: +39 (0)2 57 50 00 57 | F: +39 (0)2 57 51 81 11NIPRO D.MED AG KAZAKHSTAN :Gogol street, 39, office 1008, 050010, Almaty, KAZAKHSTAN | +7(727) 259-01-24NIPRO EUROPE - NETHERLANDS : Regus Business Center, Verlengde Poolseweg 16, 4818 CL Breda, NETHERLANDS | T: +31 (0)76 524 50 99 | F: +31 (0)76 524 46 66NIPRO D.MED NIGERIA LTD. : 5 Omowunmi Street, Oke-Afa, Isolo, Lagos, NIGERIANIPRO EUROPE - POLAND : Ul. Panska 73, 00-834 Warszawa, POLAND | T: +48 (0)22 31 47 155 | F: +48 (0)22 31 47 152NIPRO EUROPE NV - PORTUGAL : Avd. Da Liberdade 249, 1° Andar, 1205-143 Lisboa, PORTUGAL

NIPRO EUROPE - RUSSIA : 12 Krasnopresnenskaya Nab., Office 1407, entrance 6, 123610 Moscow, RUSSIA | T: +7 (0)495 258 1364 | T: +7 (0)495 258 1365NIPRO SENEGAL S.U.A.R.L. : 27 Avenue Georges Pompidou, Dakar, SENEGALNIPRO MEDICAL D.O.O. BEOGRAD : Bastovanska 68a, 11000 Belgrade, SERBIA | T: +381 (0)11 75 15 578NIPRO MEDICAL SOUTH AFRICA (PTY) LTD : Unit 2, 4B Dwyka Street, Stikland Industria, Cape Town, 7530, SOUTH AFRICA | T: + 27 21 949-2635 | F: +27 21 949-2397226 Market Str, Fairland, Randburg, Johannesburg, 2170, SOUTH AFRICA | T: + 27 11 431 1114 / 26 | F: +27 11 431 1115NIPRO EUROPE - SPAIN : Poligono Los Frailes n° 93 y 94, Daganzo, 28814 Madrid, SPAIN | T: +34 (0)91 884 5531 | F: +34 (0)91 878 2840NIPRO D.MED SCHWEIZ GMBH : Kantonsstrasse 77, 8807 Freienbach, SWITZERLAND | T: +41 (0)55 410 40 44 | F: +41 (0)55 410 40 43NIPRO D.MED SAGLIK HIZMETLERI TIC. LTD. STI. : Aziziye Mah.Pilot Sok.17/ 6, Çankaya-ANKARA, TURKEY | T: +90 (0)312 442 21 12 | F: +90 (0)312 442 21 92NIPRO MEDICAL UK LTD. : 25 Barnes Wallis Road, Segensworth East, Fareham Hampshire PO15 5TT, UNITED KINGDOM | T: +44 148 985 48 30

Nipro Medical Europe : European Headquarters, Weihoek 3H, 1930 Zaventem, BELGIUMT: +32 (0)2 725 55 33 | F: +32 (0)2 725 70 41 | info@nipro-medicaleurope.com | www.nipro-medicaleurope.com

Please contact your local representative for more information.

Nipro Renal Care is part of Nipro Corporation Japan, a leading global healthcare company established in 1954. With over 27,000 employees worldwide, Nipro serves the Medical Device, Pharmaceutical, and Pharmaceutical Packaging industries.

Nipro Renal Care is a global market leader with over 5 decades providing renal solutions for dialysis and dialysis-related treatment. We specialize in developing dialysis machines, water treatment systems, and a comprehensive portfolio of disposable medical equipment.

In order to address the needs of patients, healthcare professionals, and procurement managers alike, Nipro Renal Care is driven by innovation and patient safety to offer the highest quality products that optimize time, effort, and costs.

BECAUSE EVERY LIFE DESERVES AFFORDABLE CARE

Bro-

BioS

can_

Touc

h i8

- 26

.Jan

.18Pr

oduc

ts are

cont

inuou

sly un

der r

eview

in th

e ligh

t of t

echn

ical a

dvan

ceme

nt; t

he ac

tual

spec

ifica

tions

may

there

fore b

e sub

ject t

o imp

rovem

ent o

r mod

ifica

tion w

ithou

t noti

ce. S

ome f

eatur

es an

d/or a

cces

sorie

s disp

layed

and d

escri

bed c

ould

be op

tiona

l on d

iffere

nt ma

rkets.

The i

nform

ation

pro

vided

does

not c

onsti

tute

an of

fer to

sell a

nd is

prov

ided f

or me

rely i

nform

ation

al pu

rpose

s. Im

ages

publi

shed

in th

e pres

ent d

ocum

ent a

re sh

own e

xclus

ively

for de

mo pu

rpose

s, are

repre

sent

ative

of th

e pos

sible

appli

catio

ns an

d migh

t be a

dapt

ed fo

r grap

hic ne

eds.

All ri

ghts

reserv

ed.